Regarding the preoperative condition, the DM-CR group had higher baseline body weight (93.85 ± 16.25 vs. 79.43 ± 9.53 kg, p = 0.010), BMI (43.73 ± 5.00 vs. 29.79 ± 3.27 kg/m2, p = 0.001), waist circumference (108.69 ± 10.22 vs. 100.45 ± 9.13 cm, p = 0.020), c-peptide (3.23 ± 1.01 vs. 2.31 ± 1.18 mg/dL, p = 0.026), and ALT level (56.08 ± 40.45 vs. 33.05 ± 25.90 U/L, p = 0.047) but with lower baseline HbA1c (8.51 ± 1.42 vs. 9.76 ± 1.41%, p = 0.016) compared to the DM-non-CR group. The gene discussed is GPT; the disease is diabetes mellitus.